Important: Help to manage your eye health during the COVID-19 pandemic. Learn more >

Resources to help manage your eye health during COVID-19 Pandemic Resources to help manage your eye health during COVID-19 Pandemic

Resources to help manage your eye health during the COVID-19 pandemic

Maintaining your health during stressful times like these is critically important, and continuing your doctor’s recommended treatment can be important for many patients during the coronavirus pandemic. If you have specific questions about treatment in relation to coronavirus, we recommend that you contact your eye doctor right away.

If you experience changes in your vision, or vision loss, call your eye doctor immediately.



With the Amsler grid, you can routinely check your vision at home. If you notice changes in your vision, don’t wait for your next office visit—call your eye doctor right away. Click to download it and print it. The grid comes with instructions.

If your financial situation has changed, remember that our patient support program EYLEA4U can provide assistance to eligible patients in many ways. Also, talk to your eye doctor to find out if he or she can assist you with additional help.


It’s important to stay connected with your eye doctor during this time. This guide can help you have a productive conversation. Click to download the guide and print it.

Helpful websites

American Academy of Ophthalmology

The American Academy of Ophthalmology’s site offers information on eye diseases and treatments, eye health news, and tips for good eye health. The site currently has a coronavirus eye safety section.

American Macular Degeneration Foundation

The American Macular Degeneration Foundation’s site offers information and healthy living tips for those living with macular degeneration. It currently has a section dedicated to COVID-19 and AMD care.

American Diabetes Association

The American Diabetes Association site offers information on diabetes management and care, including related eye conditions. It currently has a section dedicated to COVID-19.

While Regeneron Pharmaceuticals does provide financial support to patient support organizations, Regeneron does not endorse any specific patient organization. The information provided by Regeneron or these organizations is meant for informational purposes only and is not meant to replace a physician's medical advice.

Regeneron is applying our 30 years of scientific and technology expertise to combat the COVID-19 pandemic. For more on Regeneron’s scientific efforts to help address COVID-19, please visit our website.

  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, vitreous floaters, moving spots in the field of vision, and increased pressure in the eye.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit, or call 1-800-FDA-1088.


EYLEA® (aflibercept) Injection 2 mg (0.05mL) is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2020, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

EYL.20.03.0109 EYL.20.03.0109


Searching with Lea